TXMD (STOCKS)
TherapeuticsMD, Inc.
$2.430000
+0.050000 (+2.10%)
Prev close: $2.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marlan D. Walker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $29.30M
- Employees
- 1
- P/E (TTM)
- 93.10
- P/B (TTM)
- 1.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.13 | $-0.05 | -0.0790 | -154.90% |
|
Jun 2023 (Q2)
|
$-0.24 | $-0.07 | -0.1686 | -236.13% |
|
Mar 2023 (Q1)
|
$-0.37 | $0.06 | -0.4312 | -704.58% |
|
Dec 2022 (Q4)
|
$8.23 | $-1.13 | +9.3622 | +826.90% |
Financial Statements
| Revenues | $2.80M |
| Benefits Costs and Expenses | $2.79M |
| Costs And Expenses | $2.79M |
| Nonoperating Income/Loss | $1.74M |
| Operating Expenses | $4.93M |
| Depreciation and Amortization | $387.00K |
| Other Operating Expenses | -$3.24M |
| Operating Income/Loss | -$2.14M |
| Income/Loss From Continuing Operations After Tax | $73.00K |
| Income/Loss From Continuing Operations Before Tax | $10.00K |
| Income/Loss From Discontinued Operations Net Of Tax | $229.00K |
| Net Income/Loss | $302.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $302.00K |
| Net Income/Loss Available To Common Stockholders, Basic | $302.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 11,616,532 |
| Diluted Average Shares | 23,179,532 |
| Assets | $38.67M |
| Current Assets | $14.50M |
| Noncurrent Assets | $24.17M |
| Intangible Assets | $3.91M |
| Other Non-current Assets | $20.25M |
| Liabilities | $11.23M |
| Current Liabilities | $4.95M |
| Accounts Payable | $263.00K |
| Wages | $256.00K |
| Other Current Liabilities | $4.43M |
| Noncurrent Liabilities | $6.28M |
| Equity | $27.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.44M |
| Liabilities And Equity | $38.67M |
| Net Cash Flow From Operating Activities | $2.07M |
| Net Cash Flow From Operating Activities, Continuing | $2.10M |
| Net Cash Flow From Operating Activities, Discontinued | -$28.00K |
| Net Cash Flow | $2.07M |
| Net Cash Flow, Continuing | $2.10M |
| Net Cash Flow, Discontinued | -$28.00K |
| Comprehensive Income/Loss | $302.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $302.00K |
| Other Comprehensive Income/Loss | $0.00 |